Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIL 284 BS in Bronchial Asthma
NCT02249312Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 1999
- Primary completion
- Apr 2000
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of amelubant in asthma, sponsored by Boehringer Ingelheim. Started Jul 1999; status: completed.
02
Drugs
amelubant
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02249312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02249312.